Court Opinion

ID: 814411
Source: CourtListenerOpinion
Date Created: 2012-12-27 19:59:46+00
Date Added: 2024-06-11T13:33:29.071923
License: Public Domain

Case: 12-1498    Document: 47    Page: 1   Filed: 12/27/2012

           NOTE: This order is nonprecedential.

   United States Court of Appeals
       for the Federal Circuit
                __________________________

         PRONOVA BIOPHARMA NORGE AS,
                Plaintiff-Appellee,

                            v.
       TEVA PHARMACEUTICALS USA, INC.,
              Defendant-Appellant,

                           AND

        PAR PHARMACEUTICAL, INC. AND
    PAR PHARMACEUTICAL COMPANIES, INC.,
              Defendants-Appellants.
                __________________________

                     2012-1498, -1499
                __________________________

     Appeals from the United States District Court for the
 District of Delaware in consolidated case nos. 09-CV-0286
 and 09-CV-0305, Judge Sue L. Robinson.
                 __________________________

                      ON MOTION
                __________________________

                        ORDER

    Teva Pharmaceuticals USA, Inc. (“Teva”) and Par
 Pharmaceutical Companies, Inc. (collectively “Par”)
Case: 12-1498   Document: 47      Page: 2   Filed: 12/27/2012

 PRONOVA BIOPHARMA NORGE V. TEVA PHARMACEUTICALS          2

 jointly move for an extension of time, until January 16,
 2013 to file their reply briefs.

    Upon consideration thereof,

    IT IS ORDERED THAT:

    (1) The December 19, 2012 motion is granted.
    (2) The December 13, 2012 motion is withdrawn.

                                    FOR THE COURT

                                     /s/ Jan Horbaly
                                    Jan Horbaly
                                    Clerk
    s27